Mercy General Hospital is a not-for-profit private community hospital located in the East Sacramento neighborhood of Sacramento, CA.

There are 342 beds in Mercy General Hospital.

During the past decade, Mercy General Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 48 clinical trials were completed, i.e. on average, 320% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 15 clinical trials were completed. i.e. 750% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy General Hospital" #1 sponsor was "Boston Scientific Corporation" with 18 trials, followed by "Radiation Therapy Oncology Group" with 18 trials sponsored, "Edwards Lifesciences" with 8 trials sponsored, "Abbott Medical Devices" with 7 trials sponsored and "SWOG Cancer Research Network" with 7 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Mercy General Hospital" are "Coronary Artery Disease" (18 trials), "Prostate Cancer" (7 trials), "Breast Cancer" (5 trials), "Head and Neck Cancer" (5 trials) and "Aortic Valve Stenosis" (4 trials). Many other conditions were trialed in "Mercy General Hospital" in a lesser frequency.

Most popular intervention types in "Mercy General Hospital" are "Drug" (47 trials), "Device" (40 trials), "Radiation" (22 trials), "Other" (10 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (7 trials), "Placebo" (6 trials), "cetuximab" (6 trials), "docetaxel" (6 trials) and "placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mercy General Hospital" are 76 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy General Hospital". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in Mercy General Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy General Hospital, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 20 trials that are defined as “Not Applicable".

Mercy General Hospital has several departments that took part in Clinical trials: "Regional Cardiology Associates" - 19 trials, "Mercy Cancer Center - Elk Grove" - 16 trials, "Mercy General Hospital Radiation Oncology Center" - 13 trials, "Sacramento Research Medical Group" - 6 trials, "Mercy General Hospital and Dignity Health Heart and Vascular Institute" - 4 trials